Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

The 8th Joint ACTRIMS-ECTRIMS Meeting - MSVirtual2020 - To be Held September 11-13 With A Special Encore Session Featuring COVID-19 & MS and Late Breakers on September 26th

~Program to Focus on Advances and Breakthroughs in MS Research, Diagnostics and Technology~ ~Special Press Events Planned to Give Media Access to Key Leaders & Late Breaker Investigators~

Newswise — MIDDLETON, Wis., Sept. 2, 2020 -- The 8th Joint ACTRIMS-ECTRIMS Meeting, the largest international conference focused on Multiple Sclerosis (MS) research, will be held in a virtual format from September 11-13, 2020, with a special encore session featuring Late-Breaking News and a COVID-19 Session on September 26. 

At this virtual conference – MSVirtual2020 – world class scientists, neurologists, clinicians and researchers from around the world will be presenting the latest research, clinical trial outcomes and technology and diagnostic advances in multiple sclerosis (MS). 

Media registration, which is open to editors, reporters, producers, and active freelance writers and bloggers, will allow access to the full program including plenary sessions, invited speakers and platform presentations. Press Registration can be completed online here, or to expedite press registration, you can send a request directly to the Press Managers.

The MSVirtual2020 program at a glance can be found here. Key topics will cover:

  • Cutting-edge research into the cause of MS, ranging from epigenetics and genetic factors, to defining the intricate immunological and pathological pathways that inform drug discovery and therapeutic interventions. 
  • Radiological advances and machine learning approaches and how these techniques can help us better understand MS. 
  • Biomarkers of disease activity and response to therapy, which is critical for the future of personalized medicine in MS. 
  • The outcomes of recent clinical trials of new agents and interventions, innovations in symptomatic and rehabilitative therapy, and current research on MS and COVID-19.

Keynote speakers will include:

  • Opening Remarks: September 11 @ 9:00 a.m. ET 
  • Closing Remarks: September 13th @ 2:30 p.m. ET  

MSVirtual2020 will be hosting a Newsroom on Newswise that will house various media materials including press releases, videos, infographics, bios & photos of leaders and speakers, and other assets.  Newswise will also host a few Zoom press events for media only that will allow registered journalists to access and ask live questions to ACTRIMS-ECTRIMS leaders and late breaking investigators. The link to the MSVirtual2020 Newsroom is: here, or at the following link: The conference hashtag is: #MSVirtual2020. 

MSVirtual2020 Press Events:

  • Opening Press Conference with ACTRIMS and ECTRIMS Leaders with live Q&A (Media only) 
    • Friday, September 11th @ 8:00 a.m. ET
  • Virtual Coffee Break with ACTRIMS President and Q&A (Media Only) 
    • Sunday, September 13th @ 7:30 a.m. ET 
    • An opportunity to ask the President questions regarding key presentations, major research, clinical, technology and rehabilitation advances, and what's next for MS  
  • Early Availability of Embargoed Late Breaker Abstracts for Media Only (Upon Request) 
    • Thursday Morning, September 24th @ 9:00 a.m. ET
  • Late-Breaker Press Event – Live Q&A with Late Breaker and COVID-19 Investigators  (Media only) 
    • Friday, September 25th @ 9:00 a.m. ET
  • Encore Event:  Late Breaker Presentations (Open to all attendees and media) 
    • Saturday, September 26th from 9:00 - 10:30 a.m. ET
  • Encore Event:  Covid-19 and MS Special Session (For all attendees and media) 
    • Saturday, September 26th from 10:45 a.m. - 12:15 p.m. ET

Register for reporter access to contact details

8th Joint ACTRIMS-ECTRIMS, September 11-13 2020

Filters close

Showing results

110 of 3699
Released: 19-Oct-2020 4:20 PM EDT
Patients Who Had More Severe Covid-19 May Be the Best Donors for Convalescent Plasma Therapy
Johns Hopkins Bloomberg School of Public Health

Sex, age, and severity of disease may be useful in identifying COVID-19 survivors who are likely to have high levels of antibodies that can protect against the disease.

access_time Embargo lifts in 2 days
Embargo will expire: 20-Oct-2020 10:00 AM EDT Released to reporters: 19-Oct-2020 4:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 20-Oct-2020 10:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 19-Oct-2020 3:05 PM EDT
Experts haven’t changed their estimates for COVID-19 immunity duration, despite Trump's claim

We rate this claim as mostly false. Infectious disease experts did not shift from saying immunity was lifelong to saying it lasted only a few months for partisan reasons. Experts haven’t changed their estimates for immunity duration, which remains unknown. Most agree that it is not a "life-time".

Newswise: 246157_web.jpg
Released: 19-Oct-2020 1:50 PM EDT
CBD helps reduce lung damage from COVID by increasing levels of protective peptide
Medical College of Georgia at Augusta University

One way CBD appears to reduce the "cytokine storm" that damages the lungs and kills many patients with COVID-19 is by enabling an increase in levels of a natural peptide called apelin, which is known to reduce inflammation and whose levels are dramatically reduced in the face of this storm.

Released: 19-Oct-2020 1:35 PM EDT
Fear of COVID-19 raises risk of depression among Soweto's deprived communities
Cambridge University Press

A STUDY into the impact of the COVID-19 lockdown on the mental health of people in Soweto has found a significant link between symptoms of depression and how likely people felt they were to be infected.

Released: 19-Oct-2020 1:25 PM EDT
Coronavirus Test Results Are Faster but Still Too Slow For Contract Tracing, National Survey Says
Rutgers University-New Brunswick

The average test times for coronavirus results have fallen from four days in April to 2.7 days in September, but results are still too slow for effective contact tracing, according to a new nationwide survey led by researchers from Rutgers University–New Brunswick and Northeastern, Harvard and Northwestern universities.

Newswise: 246236_web.jpg
Released: 19-Oct-2020 1:15 PM EDT
Researchers investigate impact of COVID-19 on BAME businesses
Staffordshire University

Black, Asian and Minority Ethnic (BAME) businesses have had to incur considerable costs to protect their businesses through lockdown, according to academics at Staffordshire University.

Released: 19-Oct-2020 1:05 PM EDT
Criteria to predict cytokine storm in COVID-19 patients identified by Temple Researchers
Temple University Health System

Like a cold front that moves in, setting the stage for severe weather, coronavirus infection triggers showers of infection-fighting immune molecules - showers that sometimes escalate into a chaotic immune response known as a cytokine storm.

Newswise: 246249_web.jpg
Released: 19-Oct-2020 12:55 PM EDT
COVID-19 pandemic has dramatic impact on osteoporosis management, finds new global study
International Osteoporosis Foundation

A new study published prior to World Osteoporosis Day finds that the COVID-19 pandemic, which has severely affected management of non-communicable diseases, is markedly impacting the management of osteoporosis as judged by access to online FRAX fracture risk assessments.

Showing results

110 of 3699